Baidu
map

J Antimicrob Chemother:初级医疗中抗生素治疗胃肠炎常见吗?

2019-02-13 王淳 环球医学

2019年1月,荷兰学者发表在《J Antimicrob Chemother》的一项研究,考察了初级医疗中抗生素治疗胃肠炎(GE)的情况。

2019年1月,荷兰学者发表在《J Antimicrob Chemother》的一项研究,考察了初级医疗中抗生素治疗肠炎(GE)的情况。

背景:肠炎是请全科医生诊治的常见原因。然而,对于初级医疗中胃肠炎患者的抗生素处方知之甚少。本研究中,研究者量化了经验性和针对性抗生素治疗胃肠炎的比例、遵守初级医疗临床实践指南(CPG)的建议的比例以及接受诊断粪便检测(DFT)患者的抗生素耐药性程度。

方法:研究者使用160个全科医生的常规医疗数据进行了一项队列研究,包括2013~2014年的患者电子记录。提取了胃肠炎发作,并与微生物实验室记录相连从而获取DFT结果。对于每次发作,收集了患者特征、DFT结果(包括抗生素耐药试验)和抗生素处方的数据。

结果:研究者鉴别出13217例胃肠炎发作。1163例(8.8%)发作处方了抗生素治疗,最常见的是甲硝唑(n=646,4.9%)、阿奇霉素(n=254,1.9%)或环丙沙星(n=184,1.4%)。641例(5%)胃肠炎发作是经验性治疗,其中的30%(n=191)遵循了CPG推荐的抗生素选择。537例(4%)胃肠炎发作在DFT结果后处方了针对性治疗,其中的99%(n=529)遵循CPG建议。在3株沙门氏菌分离株(全部分离株的9%~13%)和1株弯曲杆菌分离株(1%)中,证实了一线或二线抗生素的非敏感性。

结论:初级医疗中,抗生素治疗GE相对不频繁,每11例发病才有1例接受治疗。经验性治疗比针对性治疗更常见,且多数是非CPG推荐的抗生素。然而,基于DFT结果的治疗遵循了CPG建议。

原始出处:

Schierenberg A, Bruijning-Verhagen PCJ, van Delft S, et.al. Antibiotic treatment of gastroenteritis in primary care. J Antimicrob Chemother. 2019 Jan 1;74(1):207-213. doi: 10.1093/jac/dky385.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2084486, encodeId=613f208448681, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Aug 18 14:29:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857753, encodeId=3f21185e75377, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Dec 13 07:29:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976774, encodeId=c0cc19e67740e, content=<a href='/topic/show?id=e52232234c8' target=_blank style='color:#2F92EE;'>#初级医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32234, encryptionId=e52232234c8, topicName=初级医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Jun 14 02:29:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345238, encodeId=7bea134523887, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Fri Feb 15 04:29:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545270, encodeId=02cb15452e0f6, content=<a href='/topic/show?id=a3e58329177' target=_blank style='color:#2F92EE;'>#胃肠炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83291, encryptionId=a3e58329177, topicName=胃肠炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85e13706708, createdName=ms9608593228839890, createdTime=Fri Feb 15 04:29:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]
    2019-08-18 xjy02
  2. [GetPortalCommentsPageByObjectIdResponse(id=2084486, encodeId=613f208448681, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Aug 18 14:29:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857753, encodeId=3f21185e75377, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Dec 13 07:29:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976774, encodeId=c0cc19e67740e, content=<a href='/topic/show?id=e52232234c8' target=_blank style='color:#2F92EE;'>#初级医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32234, encryptionId=e52232234c8, topicName=初级医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Jun 14 02:29:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345238, encodeId=7bea134523887, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Fri Feb 15 04:29:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545270, encodeId=02cb15452e0f6, content=<a href='/topic/show?id=a3e58329177' target=_blank style='color:#2F92EE;'>#胃肠炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83291, encryptionId=a3e58329177, topicName=胃肠炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85e13706708, createdName=ms9608593228839890, createdTime=Fri Feb 15 04:29:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2084486, encodeId=613f208448681, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Aug 18 14:29:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857753, encodeId=3f21185e75377, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Dec 13 07:29:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976774, encodeId=c0cc19e67740e, content=<a href='/topic/show?id=e52232234c8' target=_blank style='color:#2F92EE;'>#初级医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32234, encryptionId=e52232234c8, topicName=初级医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Jun 14 02:29:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345238, encodeId=7bea134523887, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Fri Feb 15 04:29:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545270, encodeId=02cb15452e0f6, content=<a href='/topic/show?id=a3e58329177' target=_blank style='color:#2F92EE;'>#胃肠炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83291, encryptionId=a3e58329177, topicName=胃肠炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85e13706708, createdName=ms9608593228839890, createdTime=Fri Feb 15 04:29:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2084486, encodeId=613f208448681, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Aug 18 14:29:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857753, encodeId=3f21185e75377, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Dec 13 07:29:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976774, encodeId=c0cc19e67740e, content=<a href='/topic/show?id=e52232234c8' target=_blank style='color:#2F92EE;'>#初级医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32234, encryptionId=e52232234c8, topicName=初级医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Jun 14 02:29:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345238, encodeId=7bea134523887, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Fri Feb 15 04:29:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545270, encodeId=02cb15452e0f6, content=<a href='/topic/show?id=a3e58329177' target=_blank style='color:#2F92EE;'>#胃肠炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83291, encryptionId=a3e58329177, topicName=胃肠炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85e13706708, createdName=ms9608593228839890, createdTime=Fri Feb 15 04:29:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2084486, encodeId=613f208448681, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Aug 18 14:29:00 CST 2019, time=2019-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857753, encodeId=3f21185e75377, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Fri Dec 13 07:29:00 CST 2019, time=2019-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976774, encodeId=c0cc19e67740e, content=<a href='/topic/show?id=e52232234c8' target=_blank style='color:#2F92EE;'>#初级医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32234, encryptionId=e52232234c8, topicName=初级医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Jun 14 02:29:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345238, encodeId=7bea134523887, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Fri Feb 15 04:29:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545270, encodeId=02cb15452e0f6, content=<a href='/topic/show?id=a3e58329177' target=_blank style='color:#2F92EE;'>#胃肠炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83291, encryptionId=a3e58329177, topicName=胃肠炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85e13706708, createdName=ms9608593228839890, createdTime=Fri Feb 15 04:29:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]

相关资讯

2018 加拿大初级医疗中心血管疾病的预防和管理指南(更新版)

该指南直接面向初级医疗卫生保健人员提供了对有进展为慢性心血管疾病患者的管理指南。全文共包括77条指导建议,包括55条新增或更新的建议。 

2018 BC指南:初级医疗中阿片类使用障碍的诊断和管理

2018年6月,不列颠哥伦比亚省临床实践指南中心(BC)发布了初级医疗中阿片类使用障碍的诊断和管理指南,指南主要针对初级医疗中阿片类使用障碍的诊断和管理提供指导建议,涉及丁丙诺啡以及纳洛酮的诱导和维持治疗。

Baidu
map
Baidu
map
Baidu
map